Strategies for Improving Influenza Vaccination Rates in Patients with Chronic Renal Disease.
Identifieur interne : 000011 ( Main/Exploration ); précédent : 000010; suivant : 000012Strategies for Improving Influenza Vaccination Rates in Patients with Chronic Renal Disease.
Auteurs : Kevin Schulte ; Helen Schierke ; Miguel Tamayo ; Lutz Hager ; Roland Engehausen ; Matthias Raspe ; Ralf-Harto Hübner ; Georg Schlieper ; Christoph Borzikowsky ; Andreas Urbschat ; Sven Auerswald ; Ulrich Kunzendorf ; Thorsten FeldkampSource :
- Deutsches Arzteblatt international [ 1866-0452 ] ; 2019.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Allemagne (MeSH), Communication (MeSH), Défaillance rénale chronique (MeSH), Femelle (MeSH), Grippe humaine (prévention et contrôle), Humains (MeSH), Insuffisance rénale chronique (MeSH), Mâle (MeSH), Sujet âgé (MeSH), Vaccination (MeSH), Vaccins antigrippaux (MeSH), Éducation du patient comme sujet (MeSH), Études prospectives (MeSH).
- MESH :
- Wicri :
- geographic : Allemagne.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Communication (MeSH), Female (MeSH), Germany (MeSH), Humans (MeSH), Influenza Vaccines (MeSH), Influenza, Human (prevention & control), Kidney Failure, Chronic (MeSH), Male (MeSH), Middle Aged (MeSH), Patient Education as Topic (MeSH), Prospective Studies (MeSH), Renal Insufficiency, Chronic (MeSH), Vaccination (MeSH).
- MESH :
- chemical : Influenza Vaccines.
- geographic : Germany.
- prevention & control : Influenza, Human.
- Adult, Aged, Communication, Female, Humans, Kidney Failure, Chronic, Male, Middle Aged, Patient Education as Topic, Prospective Studies, Renal Insufficiency, Chronic, Vaccination.
Abstract
BACKGROUND
The influenza vaccination rate among older and chronically ill patients in Germany has declined in the past decade in spite of vaccination campaigns.
METHODS
The influenza vaccination rate among persons with chronic renal disease was studied with the aid of billing data from various Associations of Statutory Health Insurance Physicians (Kassenärztliche Vereinigungen, ASHIPs) in Germany. It was tested in a randomized controlled trial whether a written vaccination appeal, sent by physicians to patients, led to an increase in the vaccination rate. It was tested in a further such trial whether the vaccination rate among patients with renal disease could be improved by an appeal for vaccination that was sent by the ASHIPs to the treating nephrologists. Finally, it was also tested in a prospective interventional study whether the vaccination rate could be improved by an appeal for vaccination sent by a health- insurance carrier directly to the patients.
RESULTS
In 2012-2017, the vaccination rate among persons with chronically impaired renal function ranged from 41.1% to 46.9%; it ranged from 31.7% to 33.7% in kidney transplant recipients and from 42.7% to 44.7% in dialysis patients. An appeal for vaccination that was sent from physicians to patients raised the vaccination rate by 8.3% in the intervention group compared to the control group (p = 0.03; number needed to treat [NNT]: 13). On the other hand, an appeal for vaccination that was sent to the nephrologists lowered the vaccination rate by 0.8% in the intervention group compared to the control group. Finally, an appeal for vaccination that was sent by the health-insurance fund to the patients raised the vaccination rate by 3.2% (p<0.001; NNT: 32).
CONCLUSION
Fewer than half of all patients with chronic renal failure in Germany are vaccinated against influenza. The vaccination rate was found to be increased only after an appeal for vaccination that was sent directly to the patients. A letter sent to the treating physicians had no positive effect at all.
DOI: 10.3238/arztebl.2019.0413
PubMed: 31366435
PubMed Central: PMC6683446
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Strategies for Improving Influenza Vaccination Rates in Patients with Chronic Renal Disease.</title><author><name sortKey="Schulte, Kevin" sort="Schulte, Kevin" uniqKey="Schulte K" first="Kevin" last="Schulte">Kevin Schulte</name><affiliation><nlm:affiliation>Department of Nephrology and Hypertension. University Hospital Schleswig-Holstein; Department of Strategic Data Analysis and Health Policy North Rhine-Westphalia, North Rhine Association of Statutory Health Insurance Physicians, Düsseldorf; IKK Südwest, Saarbrücken; Medical Department, Division of Infectiology and Pneumology, Faculty of Medicine, Charite Berlin; Center for Renal, Hypertensive, and Metabolic Diseases, Hanover; Institute of Medical Informatics and Statistics, University of Kie; Division of Information Technology-Analysis and Development, Schleswig-Holstein Association of Statutory Health Insurance Physicians, Bad Segeberg; Thuringia Association of Statutory Health Insurance Physicians, Weimar.</nlm:affiliation><wicri:noCountry code="subField">Weimar</wicri:noCountry></affiliation></author><author><name sortKey="Schierke, Helen" sort="Schierke, Helen" uniqKey="Schierke H" first="Helen" last="Schierke">Helen Schierke</name></author><author><name sortKey="Tamayo, Miguel" sort="Tamayo, Miguel" uniqKey="Tamayo M" first="Miguel" last="Tamayo">Miguel Tamayo</name></author><author><name sortKey="Hager, Lutz" sort="Hager, Lutz" uniqKey="Hager L" first="Lutz" last="Hager">Lutz Hager</name></author><author><name sortKey="Engehausen, Roland" sort="Engehausen, Roland" uniqKey="Engehausen R" first="Roland" last="Engehausen">Roland Engehausen</name></author><author><name sortKey="Raspe, Matthias" sort="Raspe, Matthias" uniqKey="Raspe M" first="Matthias" last="Raspe">Matthias Raspe</name></author><author><name sortKey="Hubner, Ralf Harto" sort="Hubner, Ralf Harto" uniqKey="Hubner R" first="Ralf-Harto" last="Hübner">Ralf-Harto Hübner</name></author><author><name sortKey="Schlieper, Georg" sort="Schlieper, Georg" uniqKey="Schlieper G" first="Georg" last="Schlieper">Georg Schlieper</name></author><author><name sortKey="Borzikowsky, Christoph" sort="Borzikowsky, Christoph" uniqKey="Borzikowsky C" first="Christoph" last="Borzikowsky">Christoph Borzikowsky</name></author><author><name sortKey="Urbschat, Andreas" sort="Urbschat, Andreas" uniqKey="Urbschat A" first="Andreas" last="Urbschat">Andreas Urbschat</name></author><author><name sortKey="Auerswald, Sven" sort="Auerswald, Sven" uniqKey="Auerswald S" first="Sven" last="Auerswald">Sven Auerswald</name></author><author><name sortKey="Kunzendorf, Ulrich" sort="Kunzendorf, Ulrich" uniqKey="Kunzendorf U" first="Ulrich" last="Kunzendorf">Ulrich Kunzendorf</name></author><author><name sortKey="Feldkamp, Thorsten" sort="Feldkamp, Thorsten" uniqKey="Feldkamp T" first="Thorsten" last="Feldkamp">Thorsten Feldkamp</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:31366435</idno><idno type="pmid">31366435</idno><idno type="doi">10.3238/arztebl.2019.0413</idno><idno type="pmc">PMC6683446</idno><idno type="wicri:Area/Main/Corpus">000010</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000010</idno><idno type="wicri:Area/Main/Curation">000010</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000010</idno><idno type="wicri:Area/Main/Exploration">000010</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Strategies for Improving Influenza Vaccination Rates in Patients with Chronic Renal Disease.</title><author><name sortKey="Schulte, Kevin" sort="Schulte, Kevin" uniqKey="Schulte K" first="Kevin" last="Schulte">Kevin Schulte</name><affiliation><nlm:affiliation>Department of Nephrology and Hypertension. University Hospital Schleswig-Holstein; Department of Strategic Data Analysis and Health Policy North Rhine-Westphalia, North Rhine Association of Statutory Health Insurance Physicians, Düsseldorf; IKK Südwest, Saarbrücken; Medical Department, Division of Infectiology and Pneumology, Faculty of Medicine, Charite Berlin; Center for Renal, Hypertensive, and Metabolic Diseases, Hanover; Institute of Medical Informatics and Statistics, University of Kie; Division of Information Technology-Analysis and Development, Schleswig-Holstein Association of Statutory Health Insurance Physicians, Bad Segeberg; Thuringia Association of Statutory Health Insurance Physicians, Weimar.</nlm:affiliation><wicri:noCountry code="subField">Weimar</wicri:noCountry></affiliation></author><author><name sortKey="Schierke, Helen" sort="Schierke, Helen" uniqKey="Schierke H" first="Helen" last="Schierke">Helen Schierke</name></author><author><name sortKey="Tamayo, Miguel" sort="Tamayo, Miguel" uniqKey="Tamayo M" first="Miguel" last="Tamayo">Miguel Tamayo</name></author><author><name sortKey="Hager, Lutz" sort="Hager, Lutz" uniqKey="Hager L" first="Lutz" last="Hager">Lutz Hager</name></author><author><name sortKey="Engehausen, Roland" sort="Engehausen, Roland" uniqKey="Engehausen R" first="Roland" last="Engehausen">Roland Engehausen</name></author><author><name sortKey="Raspe, Matthias" sort="Raspe, Matthias" uniqKey="Raspe M" first="Matthias" last="Raspe">Matthias Raspe</name></author><author><name sortKey="Hubner, Ralf Harto" sort="Hubner, Ralf Harto" uniqKey="Hubner R" first="Ralf-Harto" last="Hübner">Ralf-Harto Hübner</name></author><author><name sortKey="Schlieper, Georg" sort="Schlieper, Georg" uniqKey="Schlieper G" first="Georg" last="Schlieper">Georg Schlieper</name></author><author><name sortKey="Borzikowsky, Christoph" sort="Borzikowsky, Christoph" uniqKey="Borzikowsky C" first="Christoph" last="Borzikowsky">Christoph Borzikowsky</name></author><author><name sortKey="Urbschat, Andreas" sort="Urbschat, Andreas" uniqKey="Urbschat A" first="Andreas" last="Urbschat">Andreas Urbschat</name></author><author><name sortKey="Auerswald, Sven" sort="Auerswald, Sven" uniqKey="Auerswald S" first="Sven" last="Auerswald">Sven Auerswald</name></author><author><name sortKey="Kunzendorf, Ulrich" sort="Kunzendorf, Ulrich" uniqKey="Kunzendorf U" first="Ulrich" last="Kunzendorf">Ulrich Kunzendorf</name></author><author><name sortKey="Feldkamp, Thorsten" sort="Feldkamp, Thorsten" uniqKey="Feldkamp T" first="Thorsten" last="Feldkamp">Thorsten Feldkamp</name></author></analytic><series><title level="j">Deutsches Arzteblatt international</title><idno type="eISSN">1866-0452</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Communication (MeSH)</term><term>Female (MeSH)</term><term>Germany (MeSH)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (MeSH)</term><term>Influenza, Human (prevention & control)</term><term>Kidney Failure, Chronic (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Patient Education as Topic (MeSH)</term><term>Prospective Studies (MeSH)</term><term>Renal Insufficiency, Chronic (MeSH)</term><term>Vaccination (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Allemagne (MeSH)</term><term>Communication (MeSH)</term><term>Défaillance rénale chronique (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Humains (MeSH)</term><term>Insuffisance rénale chronique (MeSH)</term><term>Mâle (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Vaccination (MeSH)</term><term>Vaccins antigrippaux (MeSH)</term><term>Éducation du patient comme sujet (MeSH)</term><term>Études prospectives (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Germany</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Communication</term><term>Female</term><term>Humans</term><term>Kidney Failure, Chronic</term><term>Male</term><term>Middle Aged</term><term>Patient Education as Topic</term><term>Prospective Studies</term><term>Renal Insufficiency, Chronic</term><term>Vaccination</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Allemagne</term><term>Communication</term><term>Défaillance rénale chronique</term><term>Femelle</term><term>Humains</term><term>Insuffisance rénale chronique</term><term>Mâle</term><term>Sujet âgé</term><term>Vaccination</term><term>Vaccins antigrippaux</term><term>Éducation du patient comme sujet</term><term>Études prospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>The influenza vaccination rate among older and chronically ill patients in Germany has declined in the past decade in spite of vaccination campaigns.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>The influenza vaccination rate among persons with chronic renal disease was studied with the aid of billing data from various Associations of Statutory Health Insurance Physicians (Kassenärztliche Vereinigungen, ASHIPs) in Germany. It was tested in a randomized controlled trial whether a written vaccination appeal, sent by physicians to patients, led to an increase in the vaccination rate. It was tested in a further such trial whether the vaccination rate among patients with renal disease could be improved by an appeal for vaccination that was sent by the ASHIPs to the treating nephrologists. Finally, it was also tested in a prospective interventional study whether the vaccination rate could be improved by an appeal for vaccination sent by a health- insurance carrier directly to the patients.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>In 2012-2017, the vaccination rate among persons with chronically impaired renal function ranged from 41.1% to 46.9%; it ranged from 31.7% to 33.7% in kidney transplant recipients and from 42.7% to 44.7% in dialysis patients. An appeal for vaccination that was sent from physicians to patients raised the vaccination rate by 8.3% in the intervention group compared to the control group (p = 0.03; number needed to treat [NNT]: 13). On the other hand, an appeal for vaccination that was sent to the nephrologists lowered the vaccination rate by 0.8% in the intervention group compared to the control group. Finally, an appeal for vaccination that was sent by the health-insurance fund to the patients raised the vaccination rate by 3.2% (p<0.001; NNT: 32).</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>Fewer than half of all patients with chronic renal failure in Germany are vaccinated against influenza. The vaccination rate was found to be increased only after an appeal for vaccination that was sent directly to the patients. A letter sent to the treating physicians had no positive effect at all.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31366435</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1866-0452</ISSN><JournalIssue CitedMedium="Internet"><Volume>116</Volume><Issue>23-24</Issue><PubDate><Year>2019</Year><Month>Jun</Month><Day>10</Day></PubDate></JournalIssue><Title>Deutsches Arzteblatt international</Title><ISOAbbreviation>Dtsch Arztebl Int</ISOAbbreviation></Journal><ArticleTitle>Strategies for Improving Influenza Vaccination Rates in Patients with Chronic Renal Disease.</ArticleTitle><Pagination><MedlinePgn>413-419</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3238/arztebl.2019.0413</ELocationID><ELocationID EIdType="pii" ValidYN="Y">arztebl.2019.0413</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The influenza vaccination rate among older and chronically ill patients in Germany has declined in the past decade in spite of vaccination campaigns.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The influenza vaccination rate among persons with chronic renal disease was studied with the aid of billing data from various Associations of Statutory Health Insurance Physicians (Kassenärztliche Vereinigungen, ASHIPs) in Germany. It was tested in a randomized controlled trial whether a written vaccination appeal, sent by physicians to patients, led to an increase in the vaccination rate. It was tested in a further such trial whether the vaccination rate among patients with renal disease could be improved by an appeal for vaccination that was sent by the ASHIPs to the treating nephrologists. Finally, it was also tested in a prospective interventional study whether the vaccination rate could be improved by an appeal for vaccination sent by a health- insurance carrier directly to the patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 2012-2017, the vaccination rate among persons with chronically impaired renal function ranged from 41.1% to 46.9%; it ranged from 31.7% to 33.7% in kidney transplant recipients and from 42.7% to 44.7% in dialysis patients. An appeal for vaccination that was sent from physicians to patients raised the vaccination rate by 8.3% in the intervention group compared to the control group (p = 0.03; number needed to treat [NNT]: 13). On the other hand, an appeal for vaccination that was sent to the nephrologists lowered the vaccination rate by 0.8% in the intervention group compared to the control group. Finally, an appeal for vaccination that was sent by the health-insurance fund to the patients raised the vaccination rate by 3.2% (p<0.001; NNT: 32).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Fewer than half of all patients with chronic renal failure in Germany are vaccinated against influenza. The vaccination rate was found to be increased only after an appeal for vaccination that was sent directly to the patients. A letter sent to the treating physicians had no positive effect at all.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schulte</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Nephrology and Hypertension. University Hospital Schleswig-Holstein; Department of Strategic Data Analysis and Health Policy North Rhine-Westphalia, North Rhine Association of Statutory Health Insurance Physicians, Düsseldorf; IKK Südwest, Saarbrücken; Medical Department, Division of Infectiology and Pneumology, Faculty of Medicine, Charite Berlin; Center for Renal, Hypertensive, and Metabolic Diseases, Hanover; Institute of Medical Informatics and Statistics, University of Kie; Division of Information Technology-Analysis and Development, Schleswig-Holstein Association of Statutory Health Insurance Physicians, Bad Segeberg; Thuringia Association of Statutory Health Insurance Physicians, Weimar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schierke</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Tamayo</LastName><ForeName>Miguel</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hager</LastName><ForeName>Lutz</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Engehausen</LastName><ForeName>Roland</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Raspe</LastName><ForeName>Matthias</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hübner</LastName><ForeName>Ralf-Harto</ForeName><Initials>RH</Initials></Author><Author ValidYN="Y"><LastName>Schlieper</LastName><ForeName>Georg</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Borzikowsky</LastName><ForeName>Christoph</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Urbschat</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Auerswald</LastName><ForeName>Sven</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kunzendorf</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Feldkamp</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Dtsch Arztebl Int</MedlineTA><NlmUniqueID>101475967</NlmUniqueID><ISSNLinking>1866-0452</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="Y">Kidney Failure, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010353" MajorTopicYN="N">Patient Education as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>04</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31366435</ArticleId><ArticleId IdType="pii">arztebl.2019.0413</ArticleId><ArticleId IdType="doi">10.3238/arztebl.2019.0413</ArticleId><ArticleId IdType="pmc">PMC6683446</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Prev Med. 2000 Jan;18(1 Suppl):97-140</Citation><ArticleIdList><ArticleId IdType="pubmed">10806982</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2002 Jun 7;20(19-20):2562-78</Citation><ArticleIdList><ArticleId IdType="pubmed">12057614</ArticleId></ArticleIdList></Reference><Reference><Citation>Dtsch Med Wochenschr. 2003 Oct 24;128(43):2267-70</Citation><ArticleIdList><ArticleId IdType="pubmed">14574642</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Public Health. 2008 Mar-Apr;99(2):133-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18457289</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Oct;52(10):945-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19529878</ArticleId></ArticleIdList></Reference><Reference><Citation>Dtsch Arztebl Int. 2010 Dec;107(48):845-50</Citation><ArticleIdList><ArticleId IdType="pubmed">21173931</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2014 Sep 29;32(43):5564-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25131739</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Feb;58(2):174-81</Citation><ArticleIdList><ArticleId IdType="pubmed">25446313</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2015 Jul 07;15:618</Citation><ArticleIdList><ArticleId IdType="pubmed">26148480</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2018 May 30;5:CD005188</Citation><ArticleIdList><ArticleId IdType="pubmed">29845606</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Prev Med. 2018 Aug;55(2):231-239</Citation><ArticleIdList><ArticleId IdType="pubmed">29910118</ArticleId></ArticleIdList></Reference><Reference><Citation>Dtsch Arztebl Int. 2018 Oct 26;115(43):723-730</Citation><ArticleIdList><ArticleId IdType="pubmed">30518471</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Netw Open. 2018 Nov 2;1(7):e184852</Citation><ArticleIdList><ArticleId IdType="pubmed">30646392</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2019 Feb 2;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">30715278</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1994 Sep 22;331(12):778-84</Citation><ArticleIdList><ArticleId IdType="pubmed">8065407</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 1998 Sep 14;158(16):1769-76</Citation><ArticleIdList><ArticleId IdType="pubmed">9738606</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Auerswald, Sven" sort="Auerswald, Sven" uniqKey="Auerswald S" first="Sven" last="Auerswald">Sven Auerswald</name><name sortKey="Borzikowsky, Christoph" sort="Borzikowsky, Christoph" uniqKey="Borzikowsky C" first="Christoph" last="Borzikowsky">Christoph Borzikowsky</name><name sortKey="Engehausen, Roland" sort="Engehausen, Roland" uniqKey="Engehausen R" first="Roland" last="Engehausen">Roland Engehausen</name><name sortKey="Feldkamp, Thorsten" sort="Feldkamp, Thorsten" uniqKey="Feldkamp T" first="Thorsten" last="Feldkamp">Thorsten Feldkamp</name><name sortKey="Hager, Lutz" sort="Hager, Lutz" uniqKey="Hager L" first="Lutz" last="Hager">Lutz Hager</name><name sortKey="Hubner, Ralf Harto" sort="Hubner, Ralf Harto" uniqKey="Hubner R" first="Ralf-Harto" last="Hübner">Ralf-Harto Hübner</name><name sortKey="Kunzendorf, Ulrich" sort="Kunzendorf, Ulrich" uniqKey="Kunzendorf U" first="Ulrich" last="Kunzendorf">Ulrich Kunzendorf</name><name sortKey="Raspe, Matthias" sort="Raspe, Matthias" uniqKey="Raspe M" first="Matthias" last="Raspe">Matthias Raspe</name><name sortKey="Schierke, Helen" sort="Schierke, Helen" uniqKey="Schierke H" first="Helen" last="Schierke">Helen Schierke</name><name sortKey="Schlieper, Georg" sort="Schlieper, Georg" uniqKey="Schlieper G" first="Georg" last="Schlieper">Georg Schlieper</name><name sortKey="Schulte, Kevin" sort="Schulte, Kevin" uniqKey="Schulte K" first="Kevin" last="Schulte">Kevin Schulte</name><name sortKey="Tamayo, Miguel" sort="Tamayo, Miguel" uniqKey="Tamayo M" first="Miguel" last="Tamayo">Miguel Tamayo</name><name sortKey="Urbschat, Andreas" sort="Urbschat, Andreas" uniqKey="Urbschat A" first="Andreas" last="Urbschat">Andreas Urbschat</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000011 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000011 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeAllemagneV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:31366435
|texte= Strategies for Improving Influenza Vaccination Rates in Patients with Chronic Renal Disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:31366435" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV4
| This area was generated with Dilib version V0.6.35. |  |